Dr. Haldorsen on the Contributions of Imaging in Endometrial Cancer

Video

Ingfrid Haldorsen, MD, University of Bergen, Haukeland University Hospital, discusses the contributions of imaging in endometrial cancer.

Ingfrid Haldorsen, MD, University of Bergen, Haukeland University Hospital, discusses the contributions of imaging in endometrial cancer.

Haldorsen says that she hopes these advances in imaging give more certainty to the surgeon regarding the stage and prognosis prior to surgery. Additionally, these advances may be able to provide more prognostic tools with which to guide adjuvant therapy after primary surgery.

Investigators are currently exploring the efficacy of various imaging technologies in the diagnosis of endometrial cancer such as PET/MRI and 3D ultrasounds. Specifically, there is a diagnostic study evaluating the accuracy of 3D ultrasounds in comparison with MRI and final histology to detect myometrial invasion of endometrial cancer (NCT03207061).

Ultimately, imaging is very important when it comes to detecting recurrent disease, Haldorsen says. Every patient should have access to imaging facilities in order to get optimal treatment, and the implications of imaging should be kept in mind by the clinician, concludes Haldorsen.

Related Videos
Emmanuel Antonarakis, MD, associate director, Translational Research, Masonic Cancer Center, University of Minnesota, Clark Endowed Professor of Medicine, University of Minnesota Medical School
Gautam Jha, MD, medical director, M Health Fairview Masonic Cancer Clinic and the Advanced Treatment Center at the M Health Fairview Clinics and Surgery Center—Minneapolis, chair, cancer committee, M Health Fairview Ridges Hospital
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute